Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Total Assets

Latest as of March 2026: CN¥9.18 Billion CNY ≈ $1.34 Billion USD

Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) holds total assets worth CN¥9.18 Billion CNY (≈ $1.34 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Yantai Dongcheng Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.

Yantai Dongcheng Pharmaceutical Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 002675 book value for net asset value and shareholders' equity analysis.

Yantai Dongcheng Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Yantai Dongcheng Pharmaceutical Co Ltd's total assets of CN¥9.18 Billion consist of 29.0% current assets and 71.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	9.4%
Accounts Receivable	CN¥1.03 Billion	11.1%
Inventory	CN¥532.57 Million	5.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥567.83 Million	6.1%
Goodwill	CN¥2.49 Billion	26.9%

Asset Composition Trend (2008–2025)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Yantai Dongcheng Pharmaceutical Co Ltd (002675) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Yantai Dongcheng Pharmaceutical Co Ltd's current assets represent 29.0% of total assets in 2025, a decrease from 69.0% in 2008.
Cash Position: Cash and equivalents constituted 9.4% of total assets in 2025, up from 5.4% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 5.0% in 2008.
Asset Diversification: The largest asset category is goodwill at 26.9% of total assets.

Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Yantai Dongcheng Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.84 Billion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.69 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	China	CN¥6.39 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.23 Billion

Yantai Dongcheng Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.71	1.60	1.44
Quick Ratio	1.38	1.21	0.96
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.08 Billion	CN¥932.18 Million	CN¥849.69 Million

Yantai Dongcheng Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Yantai Dongcheng Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.51
Latest Market Cap to Assets Ratio	0.17
Asset Growth Rate (YoY)	7.3%
Total Assets	CN¥9.26 Billion
Market Capitalization	$1.55 Billion USD

Valuation Analysis

Below Book Valuation: The market values Yantai Dongcheng Pharmaceutical Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Yantai Dongcheng Pharmaceutical Co Ltd's assets grew by 7.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual total assets of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥9.26 Billion ≈ $1.36 Billion	+7.27%
2024-12-31	CN¥8.63 Billion ≈ $1.26 Billion	+6.83%
2023-12-31	CN¥8.08 Billion ≈ $1.18 Billion	-1.16%
2022-12-31	CN¥8.18 Billion ≈ $1.20 Billion	+6.80%
2021-12-31	CN¥7.66 Billion ≈ $1.12 Billion	+3.56%
2020-12-31	CN¥7.39 Billion ≈ $1.08 Billion	+1.35%
2019-12-31	CN¥7.29 Billion ≈ $1.07 Billion	+4.70%
2018-12-31	CN¥6.97 Billion ≈ $1.02 Billion	+32.13%
2017-12-31	CN¥5.27 Billion ≈ $771.63 Million	+23.55%
2016-12-31	CN¥4.27 Billion ≈ $624.53 Million	+67.51%
2015-12-31	CN¥2.55 Billion ≈ $372.84 Million	+82.86%
2014-12-31	CN¥1.39 Billion ≈ $203.89 Million	+13.42%
2013-12-31	CN¥1.23 Billion ≈ $179.77 Million	+12.88%
2012-12-31	CN¥1.09 Billion ≈ $159.26 Million	+141.19%
2011-12-31	CN¥451.24 Million ≈ $66.03 Million	+25.62%
2010-12-31	CN¥359.19 Million ≈ $52.56 Million	+34.55%
2009-12-31	CN¥266.96 Million ≈ $39.07 Million	+36.84%
2008-12-31	CN¥195.09 Million ≈ $28.55 Million	--

About Yantai Dongcheng Pharmaceutical Co Ltd

SHE:002675 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.55 Billion

CN¥10.57 Billion CNY

Market Cap Rank

#6978 Global

#1442 in China

Share Price

CN¥12.82

Change (1 day)

+0.23%

52-Week Range

CN¥12.24 - CN¥18.29

All Time High

CN¥27.09